Join the ARIA alliance
ARIA is an individual member–based alliance, with a diverse array of members who seek to fulfil ARIA’s goal. Membership is free and time contributed to general member activities is voluntary.
Individuals who have relevant experience can self-nominate using pre-specified criteria found in the expression of interest (EOI) form to join ARIA. Please contact the ARIA Secretariat if you have any questions about becoming a member.
Professor Michael Gold is a Paediatric Allergist and Immunologist with conjoint positions in the Discipline of Paediatrics, University of Adelaide and is former Medical Unit Head, of the Department of Allergy and Immunology at the Women’s and Children’s Health Network. He has a research and clinical interest in the prevention of food allergy and vaccine safety. He was appointed to the World Health Organisation Global Advisory Committee for Vaccine Safety in 2010 and has been an advisor to the Australian Therapeutic Goods Administration via his appointment to a number of expert advisory groups since 2006. He has been awarded a number of Australian national research grants as a principle investigator for projects that have researched novel methods of safety surveillance including data linkage and m-Health.
Professor Gold has contributed to a number of key WHO guidelines which include the global Adverse Event Following Immunisation surveillance manual, the WHO guideline on causality assessment, a guideline for programme managers on Immunisation stress related responses and the global manual for COVID vaccine safety surveillance. He has participated in numerous WHO organised training courses to strengthen adverse event surveillance and causality assessment systems in Low and Middle Income Countries and is currently a consultant to WHO South East Asian Region, facilitating the implementation of COVID vaccine pharmacovigilance. He has contributed to the Vaccines for Africa (VACFA) initiative through research collaborations and presentations at the annual vaccinology course based at the University of Cape Town.
Kerrie Wiley is a National Health and Medical Research Council (NHMRC) Emerging Leadership Fellow, and Senior Research Fellow with the University of Sydney’s School of Public Health, in the Faculty of Medicine and Health. Kerrie’s research focuses on the social and behavioural aspects of immunisation and other preventive health behaviours, and their implications for policy and practice. Kerrie is a member of the World Health Organization ‘Measuring Behavioural and Social Drivers of Vaccination’ (BeSD) Working Group, and a founding member of the Collaboration of Social Science in Immunisation.
Professor Paul Effler is the Medical coordinator in the Communicable Disease Control Directorate for the Western Australian Department of Health.
Professor Julia Brotherton is a public health physician and Medical Director of Population Health at the Australian Centre for the Prevention of Cervical Cancer. She is Professor of Cancer Prevention Policy and Implementation at the Melbourne School of Population and Global Health, University of Melbourne, and Professorial Fellow at NCIRS.
For over fifteen years, Julia has been involved in research and policy development informing the implementation and evaluation of HPV vaccination and cervical screening programs. She was a lead investigator in Australian research which demonstrated the world’s first evidence of dramatic declines in both HPV infections and pre-cancerous cervical lesions in young women post- vaccination. She has 220 publications to date and is a member of the WHO Director General's Expert Advisory Group on Cervical Cancer Elimination.
Kylie Jenkins is a registered nurse and public health expert who is currently employed as Maternal Newborn Health Technical Advisor with the DFAT-funded Australia’s support to the Fiji health sector project. She has >15 years’ experience in international development, predominantly in the Pacific. She has expertise in immunisation programs, maternal and child health, communicable diseases and disaster management. In her role as Advisor to the DFAT-funded Fiji Health Sector Support Program 2012-2016, she worked closely with the Fiji Ministry of Health to procure and introduce three new vaccines (pneumococcal, rotavirus, and HPV vaccines) through an innovative financing system achieving high coverage. She has vast experience advising and working with governments and UN agencies. She previously worked for UNICEF where she was responsible for overseeing the UNICEF support to the Expanded Program on Immunisation (EPI) Programs in the Pacific. In addition, Kylie was the founding member of the PIPS Committee that in 2005 led to a collaborative approach to donor funding and technical support for immunisation programs. The committee coordinated 22 Pacific Island Countries and multiple donors, including Australian Aid, NZAID, JICA and SPC. This has led to Kylie having strong connections with the EPI Program Managers across the Pacific Region.
Katarzyna Bolsewicz has been involved in co-designing and implementing WHO Tailoring Immunisation Programmes (TIP) across three local health districts (LHDs) in NSW: Central Coast, Hunter New England and Mid-North Coast for the last 2 years. TIP is a strategy developed by WHO (and implemented in many European countries as well as successfully piloted in Maitland, NSW) that uses social sciences and qualitative approaches to understand the demand and supply barriers and enablers to childhood immunisation in areas of low coverage. Findings are then used by local immunisation stakeholders to design localised, appropriate strategies to get more children up to date on their immunisations. Katarzyna has been working closely with immunisation stakeholders in each LHD, including caregivers, Aboriginal and Torres Strait Islander communities, public health units, public health networks, GP practices, child and family health nurses. She is also a research fellow in social science with NCIRS, where she has been working on exploring and addressing communication barriers and enablers related to influenza vaccination experienced by Aboriginal and Torres Strait Islander communities and health providers working with these communities.
Dr Geoff Clark is a global public health and international development specialist with more than 25 years experience working for both multilateral, bilateral and national organisations in senior clinical. Management, policy and advisory roles in several countries in the Asia Pacific region. He has also held leadership roles in setting the health service agenda regionally, including developing policy processes to progress the implementation of health security, health system strengthening and health service delivery goals. He holds post-graduate qualifications in Infectious Disease’s Intelligence, Public Health, Health Management and Law and supported the Vanuatu Ministry of Health in its response to COVID 19 as the Senior Health Security Adviser.
His current role is the State Manager, Primary Health Care for the Queensland Section of the Royal Flying Doctor Service.
Dr Jane Frawley is a public health researcher focusing on immunisation and maternal and child health. She is a Senior Lecturer in Public health at the School of Public Health within the Faculty of Health at UTS and was a National Health and Medical Research Council (NHMRC) Early Career Fellow from 2017-2021.
The COVID-19 pandemic expanded her focus to include a more general investigation around vaccine acceptance and uptake across all age groups. Jane then led a team of immunisation experts, health communication experts, and clinicians to develop online, interactive vaccine information resources. These resources help people make decisions about vaccines for themselves and their children.
Jane is a current and founding member of the Collaboration on Social Science and Immunisation (COSSI) network. She has completed many projects with parents and health practitioners to understand behavioural and access factors impacting vaccine uptake and has presented the results of this research locally and internationally. Jane has recently started a project with a group of colleagues looking at HPV vaccine uptake in Samoa, Vanuatu and Fiji.
Professor Gulam Khandaker is a Public Health Physician and currently working as the Director of Public Health for Central Queensland Hospital and Health Service, Queensland, Australia. His research focuses on childhood development, disability, infectious diseases, vaccine preventable diseases and healthcare in high, low- and middle-income countries. Gulam's research is supported by the National Health and Medical Research Council Investigators Grant (2022-2026), Queensland Health (Queensland Advancing Clinical Research Fellowship 2019-2023) and Australian Cerebral Palsy Alliance Research Foundation.
He leads a global research program on cerebral palsy and vaccine preventable childhood disabilities in LMICs using a network of cerebral palsy registers in Bangladesh, Sri Lanka, Nepal, Indonesia, Vietnam, Zimbabwe, Ghana, Argentina, and Suriname.
Dorothy is a senior research fellow at the Kirby Institute, UNSW, and an honorary research fellow with the Centre for Women’s Infectious Disease at The Royal Women’s Hospital in Melbourne. She holds a Doctorate in epidemiology and a Master of Public Health. Dorothy's research focuses on development and implementation of novel public health surveillance systems, and the evaluation of vaccination and screening strategies for the prevention of HPV and related diseases.
Since 2014, she has led the development and implementation of a Commonwealth Department of Health funded National HPV Monitoring Program that is evaluating the long-term impact of HPV vaccination on HPV infections. This program has provided the basis for well-cited publications on the impact of Australia’s vaccination program. The program methodology underpinned the design of a world-first project to evaluate the impact of one- and two-dose HPV vaccine schedules in South Africa funded by NHMRC and the Gates Foundation. Currently, she also coordinates the implementation of serological surveys to track the spread of SARS-CoV-2 infection in Australia.
Andrew is a clinical epidemiologist with over 20 years’ experience in international public health, sexually transmitted and infectious disease research. Andrew has held a joint appointment with the Papua New Guinea Institute of Medical Research (PNGIMR) and the Kirby Institute for Infection and Immunity in Society, Faculty of Medicine, UNSW Sydney, since 2010. In the last 20 years he has designed and led multi-disciplinary research teams in Australia, Kenya, Myanmar, Papua New Guinea, Solomon Islands, Tanzania, United Kingdom and Vanuatu. In 2007, he established an international collaborative research group at the PNGIMR, where he was head of the Sexual and Reproductive Health Unit and Deputy Director from 2010 to 2015. His research in the last decade has focused on evaluating innovative solutions to improve women’s reproductive health in high-burden, low-resource settings.
Andrew is lead investigator of an NHMRC Centre for Research Excellence in Cervical Cancer Control grant (C4 CRE; 2017-22) and an NHMRC Project Grant to evaluate the impact of 2-dose and 1-dose HPV vaccination schedules on community level HPV prevalence among adolescent girls in South Africa (2019-24); and leads an NHMRC-funded field trial of point-of-care HPV testing and treatment for cervical screening in PNG (2015-20). He is a member of the PNG National Technical Advisory Committee on HPV Vaccination (2016-present) and the PNG National Technical Working Group on Comprehensive Cervical Cancer Control (2017-present). He has been a board member of the PNG National Cancer Foundation since its inception in 2013. He jointly organised a regional meeting on cervical cancer in the Pacific, held in Fiji and attended by representatives from seven countries, WHO, UNFPA, and UNICEF that led to a joint Call to Action on Cervical Cancer Elimination (December 2019). He was subsequently asked to take a lead role in progressing the elimination agenda in PNG and Vanuatu from 2020.
Dr André Wattiaux is a dual trained paediatrician and public health physician who is currently the Medical Director of the Gold Coast Public Health Unit. He has gained knowledge and experience of public health practice, research and policy with a focus on immunisation and vaccine-preventable diseases at local, state and national levels through more than 15 years practicing in the US, the UK, the Gambia and Indigenous Australia with special attention to vulnerable populations. André’s experience has spanned
from contributing to the setting up of a nationwide surveillance system in the Gambia monitoring invasive pneumococcal disease to leading the roll-out of pandemic influenza vaccines across the Northern Territory of Australia including remote Indigenous communities.
He has previously served as a member of a technical support team based at NCIRS supporting the Australian Technical Advisory Group on Immunisation (ATAGI) and as a member of the Australian National Immunisation Committee (NIC) to provide advice on the National Immunisation Program (NIP).